BetaShares Global Healthcare ETF - Currency Hedged (ASX:DRUG) - Stock Price, News & Analysis

DRUG Stock Overview

BetaShares Global Healthcare ETF - Currency Hedged is an exchange traded fund launched and managed by BetaShares Capital Limited.

About the company

DRUG fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

BetaShares Global Healthcare ETF - Currency Hedged Competitors

Price History & Performance

Summary of all time highs, changes and price drops for BetaShares Global Healthcare ETF - Currency Hedged
Historical stock prices
Current Share Price	AU$8.39
52 Week High	AU$8.70
52 Week Low	AU$7.30
Beta	0
1 Month Change	-1.18%
3 Month Change	1.33%
1 Year Change	7.84%
3 Year Change	13.38%
5 Year Change	47.19%
Change since IPO	67.13%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	DRUG	AU Capital Markets	AU Market
7D	0.7%	-0.2%	0.7%
1Y	7.8%	6.2%	6.3%

Return vs Industry: DRUG exceeded the Australian Capital Markets industry which returned 6.2% over the past year.

Return vs Market: DRUG exceeded the Australian Market which returned 6.3% over the past year.

Price Volatility

Is DRUG's price volatile compared to industry and market?
DRUG volatility
DRUG Average Weekly Movement	1.7%
Capital Markets Industry Average Movement	4.7%
Market Average Movement	9.0%
10% most volatile stocks in AU Market	17.4%
10% least volatile stocks in AU Market	3.5%

Stable Share Price: DRUG has not had significant price volatility in the past 3 months.

Volatility Over Time: DRUG's weekly volatility (2%) has been stable over the past year.

About the Company

Founded	Employees	CEO	Website
n/a	n/a	n/a	n/a

BetaShares Global Healthcare ETF - Currency Hedged is an exchange traded fund launched and managed by BetaShares Capital Limited. It invests in the public equity markets across the globe excluding Australia. The fund invests directly and also through foreign currency forward contracts in the stocks of companies operating in the healthcare sector.

BetaShares Global Healthcare ETF - Currency Hedged Fundamentals Summary

How do BetaShares Global Healthcare ETF - Currency Hedged's earnings and revenue compare to its market cap?
DRUG fundamental statistics
Market cap	n/a
Earnings (TTM)	AU$0
Revenue (TTM)	n/a

n/a

P/E Ratio

n/a

P/S Ratio

Is DRUG overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
DRUG income statement (TTM)
Revenue	AU$0
Cost of Revenue	AU$0
Gross Profit	AU$0
Other Expenses	AU$0
Earnings	AU$0

Last Reported Earnings

n/a

Next Earnings Date

n/a

Earnings per share (EPS)	0
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0.0%

How did DRUG perform over the long term?

See historical performance and comparison